Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

262728293031323334

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

19th Jan 2024 09:28

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH. Read More

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

16th Jan 2024 11:58

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates. Read More

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

GSK bolsters respiratory pipeline with USD1.4 billion acquisition

9th Jan 2024 11:51

(Alliance News) - GSK PLC's latest acquisition of Aiolos Bio Inc reflects its focus on respiratory diseases, with the latter's key asset potentially offering a chance to differentiate from rivals, Third Bridge noted. Read More

Berenberg hails AstraZeneca's Alexion as "high-value asset"

9th Jan 2024 11:43

(Alliance News) - German bank Berenberg talked up AstraZeneca PLC's Alexion Pharmaceuticals, believing it is still in good shape despite some competitors entering the market. Read More

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

3rd Jan 2024 16:52

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes. Read More

IN BRIEF: Nuformix narrows annual loss as develops drug assets

3rd Jan 2024 10:16

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses. Read More

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

3rd Jan 2024 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

3rd Jan 2024 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

3rd Jan 2024 08:58

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively. Read More

C4X receives USD11 million from AstraZeneca following NRF2 trials

3rd Jan 2024 08:04

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment. Read More

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

3rd Jan 2024 07:54

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York. Read More

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

2nd Jan 2024 12:01

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December. Read More

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

2nd Jan 2024 08:48

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due. Read More

AstraZeneca and Sanofi received approval in China for RSV antibody

2nd Jan 2024 08:26

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday. Read More

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

2nd Jan 2024 07:57

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK. Read More

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

27th Dec 2023 17:02

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024. Read More

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

27th Dec 2023 12:06

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials. Read More

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

27th Dec 2023 08:48

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher. Read More

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

27th Dec 2023 08:24

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company. Read More

262728293031323334
FTSE 100 Latest
Value10,530.45
Change64.19